✦ LIBER ✦

Multicenter phase II trial of first-line irinotecan (CPT-11) and gemcitabine (GMB) in patients with unresectable pancreatic cancer

✍ Scribed by Stathopoulos, G.; Rigatos, S.; Androulakis, N.; Souglakos, J.; Kouroussis, Ch.; Dimopoulos, A.M.; Aravantinos, G.; Giannakakis, Th.; Foutzilas, G.; Stathopoulos, J.; Georgoulias, V.

Book ID: 122878589
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 198 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(01)81648-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter phase III trial comparing

A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer

✍ Stathopoulos, G P; Syrigos, K; Aravantinos, G; Polyzos, A; Papakotoulas, P; Foun 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

A multicenter, Phase II trial of weekly

A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma

✍ Mace L. Rothenberg; John V. Cox; Russell F. DeVore; John D. Hainsworth; Richard 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 2 views

## Background: This multicenter, phase ii trial was performed to evaluate the antitumor activity and toxicity of irinotecan (cpt-11) in patients with metastatic colorectal carcinoma that had recurred or progressed after 5-fluorouracil (5-fu)-based chemotherapy. ## Methods: Cpt-11 was given as a 9

A multicenter phase II study of irinotec

A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer

✍ JuanJosé Reina; Jorge Aparicio; Javier Salvador; JoséMaríaPuerto Pica; Antonio R 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 192 KB

A multicenter phase II study of gemcitab

A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer

✍ Do-Youn Oh; Yongjun Cha; In-Sil Choi; So-Young Yoon; In Keun Choi; Jee Hyun Kim; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 352 KB

First line treatment with docetaxel (D)

First line treatment with docetaxel (D) and gemcitabine (G) in patients with inoperable pancreatic cancer: a multicenter phase II study

✍ N. Androulakis; G. Stathopoulos; N. Tsavaris; G. Aravandinos; E. Samantas; P. Pa 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Irinotecan (CPT-11) as first-line monoth

Irinotecan (CPT-11) as first-line monotherapy in patients with advanced, metastatic colorectal cancer refractory to 5-fluorouracil adjuvant chemotherapy: a multicenter phase II study

✍ Matilde Navarro García; Ferrán Losa Gaspa; Hermini Manzano Alemany; Pilar García 📂 Article 📅 2002 🏛 Springer Milan 🌐 Spanish ⚖ 148 KB